Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 18/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 13/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4888027 | 0.87 | PTGS2 (0.50) | PTGS2PTGS1ABCB11ALDH1A1CDK2 | |
| SCHEMBL6169938 | 0.86 | PTGS2 (0.58) | PTGS2PTGS1ABCB11ALDH1A1CDK2 | |
| SCHEMBL4888565 | 0.86 | PTGS2 (0.67) | PTGS2PTGS1CDK2CA4 | |
| SCHEMBL8477502 | 0.85 | PTGS2 (0.51) | PTGS2PTGS1ABCB11ALDH1A1CA4 | |
| SCHEMBL6171523 | 0.84 | PTGS2 (0.54) | PTGS2PTGS1CDK2 | |
| SCHEMBL6168007 | 0.83 | PTGS2 (0.53) | PTGS2PTGS1CA4 | |
| SCHEMBL6168801 | 0.83 | PTGS2 (0.55) | PTGS2PTGS1CDK2 | |
| SCHEMBL6170654 | 0.83 | PTGS2 (0.55) | PTGS2PTGS1ABCB11ALDH1A1CDK2 | |
| SCHEMBL6167687 | 0.83 | PTGS2 (0.55) | PTGS2PTGS1ABCB11ALDH1A1CDK2 | |
| SCHEMBL8800207 | 0.82 | CA2 (0.59) | PTGS2PTGS1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1528059-A2 | Substituted isoxazoles for the treatment of inflammation | G.D. Searle LLC (US) | 2005-05-04 | — | — | EP | claimed |
| EP-0809636-B1 | SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2002-09-04 | — | — | EP | claimed |
| EP-1223167-A2 | Substituted isoxazoles for the treatment of inflammation | G.D. Searle & Co. (US) | 2002-07-17 | — | — | EP | claimed |
| EP-1528059-A2 | Substituted isoxazoles for the treatment of inflammation | G.D. Searle LLC (US) | 2005-05-04 | — | — | EP | disclosed |
| CN-1442139-A | Medicinal composition for treating inflammation | SEARLE & CO (US) | 2003-09-17 | — | — | CN | disclosed |
| CN-1107058-C | Substituted isoxazoles for the treatment of disorders | SEARLE & CO (US) | 2003-04-30 | — | — | CN | disclosed |
| EP-0809636-B1 | SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-1223167-A2 | Substituted isoxazoles for the treatment of inflammation | G.D. Searle & Co. (US) | 2002-07-17 | — | — | EP | disclosed |
| CN-1181075-A | Substituted isoxazoles for the treatment of disorders | SEARLE & CO (US) | 1998-05-06 | — | — | CN | disclosed |
| EP-0809636-A1 | SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-12-03 | — | — | EP | disclosed |
| WO-1996025405-A1 | SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-22 | — | — | WO | disclosed |